Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v1-EN
Language English English
Date Updated 2022-11-29 2022-11-02
Drug Identification Number 02273276 02273276
Brand name CADUET CADUET
Common or Proper name CADUET CADUET
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients ATORVASTATIN AMLODIPINE ATORVASTATIN AMLODIPINE
Strength(s) 80MG 5MG 80MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90 90
ATC code C10BX C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-16 2022-09-16
Estimated end date Unknown Unknown
Actual end date 2022-11-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments